Hopewell, P <br/><br/>
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Nov 1992 
 - S282-95 p.  digital 
<br/><br/> Publication Type: Guideline; Journal Article; Practice Guideline; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1093/clind/15.supplement_1.s282  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antitubercular Agents--therapeutic use<br/>Child<br/>Clinical Protocols--standards<br/>Clinical Trials as Topic--standards<br/>Clinical Trials, Phase I as Topic--standards<br/>Clinical Trials, Phase II as Topic--standards<br/>Clinical Trials, Phase III as Topic--standards<br/>Humans<br/>Research Design<br/>Tuberculosis--drug therapy